¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acta crystallographica. Section C, Crystal structure communications."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • median section
    Á¤Áߴܸé
  • optical section
    ±¤ÇÐÀýÆí
  • postmortem cesarean section
    »çÈÄÁ¦¿ÕÀý°³
  • paraffin section
    ÆÄ¶óÇÉÀýÆí
  • section
    1. Àý´Ü 2. ´Ü¸é 3. ÀýÆí 4. Àý°³
  • sagittal section
    1. ½Ã»óÀý´Ü 2. ½Ã»ó´Ü¸é
  • serial section
    1. ¿¬¼ÓÀýÆí 2. ¿¬¼Ó´Ü¸é
  • tangential section
    ºñ½ºµëÀý´Ü, Á¢¼±Àý´Ü
  • ultrathin section
    ÃʹÚÀýÆí
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cross-section
    °¡·Î´Ü¸é
  • celloidin section
    ¼¿·ÎÀ̵òÀýÆí
  • cesarean section
    Á¦¿ÕÀý°³(¼ú)
  • cross section
    ´Ü¸éÀû, È®À²ÇÔ¼ö
  • cross section radiography
    (¢¡tomography) ´ÜÃþÃÔ¿µ¼ú
  • frozen section
    µ¿°áÀýÆí
  • longitudinal section
    ¼¼·Î´Ü¸é
  • low cervical cesarean section
    ¾Æ·¡ÀڱøñÁ¦¿ÕÀý°³¼ú, ÇϺÎÀڱðæºÎÁ¦¿ÕÀý°³¼ú
  • optical section
    ±¤ÇÐÀýÆí
  • paraffin section
    ÆÄ¶óÇÉÀýÆí
  • postmortem cesarean section
    »çÈÄÁ¦¿ÕÀý°³
  • section
    Àý´Ü, ´Ü¸é, ÀýÆí, Àý°³
  • sagittal section
    ½Ã»óÀý´Ü
  • serial section
    ¿¬¼ÓÀýÆí
  • tangential section
    ºñ½ºµëÀý´Ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • indigotin crystal
    Àεð°íƾ°áÁ¤
  • piezoelectric crystal
    ¾ÐÀü °áÁ¤
  • positive crystal
    ¾ç¼º°áÁ¤(åÕàõÌ¿ïÜ).
  • potassium urate crystal
    ¿ä»êÄ®·ý°áÁ¤
  • radiographic media crystal
    ¹æ»ç¼±ÃÔ¿µ¹°Áú°áÁ¤
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ultrathin section
    ÃʹÚÀýÆí(õ±ÚÝôîø¸).
  • ultrathin section
    ÃʹÚÀýÆí(õ±ÚÝôîø¸)
  • vaginal section
    Áú½ÄÀý°³(òóãÒôîËÒ).
  • alveolar structure
    Æ÷»ó±¸Á¶(¡­Ï°ðã).
  • alveolar structure
    ÆóÆ÷±¸Á¶(¡­Ï°ðã)
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antigenic structure
    Ç׿ø±¸Á¶(¡­Ï°ðã).
  • atomic structure
    ¿øÀÚ±¸Á¶(¡­Ï°ðã).
  • atomic structure
    ¿øÀÚ±¸Á¶
  • bone structure
    »À±¸Á¶, °ñ±¸Á¶(Íéϰðã).
  • chain structure
    ¿¬¼â±¸Á¶(ææáðϰðã).
  • chemical structure
    È­ÇÐÀû ±¸Á¶
  • chemical structure
    È­Çб¸Á¶(¡­Ï°ðã).
  • cognitive structure
    ÀÎÁö±¸Á¶(ìãò±Ï°ðã)
  • core structure
    Á᫐ ±¸Á¶¹°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • quaternary structure
    »çÂ÷(ÞÌó­) ±¸Á¶(ϰðã).
  • quinary structure
    ¿ÀÂ÷(çéó­) ±¸Á¶(ϰðã).
  • secondary structure
    ÀÌÂ÷ ±¸Á¶(ì£ó­Ï°ðã)
  • sigma structure
    ½Ã±×¸¶±¸Á¶(ϰðã)
  • solenoid structure
    ¼Ö·¹³ëÀÌµå ±¸Á¶(ϰðã)
  • super-secondary structure
    ÃÊÀÌÂ÷ ±¸Á¶(õ±ì£ó­Ï°ðã)
  • tertiary structure
    »ïÂ÷±¸Á¶ (ß²ó­Ï°ðã)
  • theta structure
    ½ÃŸ ±¸Á¶(ϰðã)
  • x-ray structure
    X¼±(àÊ) ±¸Á¶(ϰðã)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CCF cancer coagulation factor; cardiolipin complement fixation; carotid-cavernous fistula; centrifuged c...
CCL carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca...
CFSE crystal field stabilization energy
CLC Charcot-Leyden crystal; Clerc-Levy-Critesco [syndrome]
CLD chloride diarrhea; chronic liver disease; chronic lung disease; congenital limb deficiency; crystal ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
QCM Quartz Crystal Microbalance
ICP insecticidal crystal protein
LC liquid crystal
CASE Computer Automated Structure Evaluation
DLS Dimer Linkage Structure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • thin section
    ¾ãÀº ÀýÆí, ¼¼ÀýÆí
  • ancillary structure
    º¸Á¶ Á¶Á÷
  • atomic structure
    ¿øÀÚ ±¸Á¶
  • bone structure
    °ñ°Ý, »À ±¸Á¶, °ñ ±¸Á¶
    µ¿¹°ÀÇ ¸öÀ» ÁöÅÊÇϰí üÇüÀ» Çü¼ºÇÏ´Â ±â°ü. ü°Ý ¶Ç´Â ÀÚ¼¼¸¦ ÁöÅÊÇϸç, ¿îµ¿ÀÇ Åä´ë°¡ µÇ°í, ³»ÀåÀÇ ¸ðµç ±â°üÀ» º¸È£ÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ôÃßµ¿¹°¿¡¼­´Â ±âº»ÀûÀ¸·Î °ñ°Ý¿¡ °øÅëÁ¡ÀÌ Àִµ¥, µÎ°ñ°ú ôÃß°¡ Áß½ÉÀ» ÀÌ·ç¸ç, °Å±â¿¡ »çÁö°ñÀÌ À̾îÁø´Ù. µ¿¹°ÀÇ Á¾·ù¿¡ µû¶ó¼­ °ñ°ÝÀÇ Çü»óÀ̳ª ¼ö·® µî¿¡´Â Â÷À̰¡ ÀÖ´Ù. °ñ°ÝÀÇ °áÇÕ ¹æ¹ý¿¡´Â ´ÙÀ½ÀÇ 3Á¾·ù°¡ ÀÖ´Ù. ¨ç °üÀý °áÇÕ : °ñ°ÝÀÇ ´ëºÎºÐÀº °üÀý·Î¼­ ¿òÁ÷À̵µ·Ï µÇ¾î ÀÖ´Ù. ¨è ºÀÇÕ : µÎ°³°ñÀº °ñ°ÝÀÇ °áÇպκÐÀÌ Åé´Ïó·³ µÇ¾î ÀÖ¾î Åé´Ï¹ÙÄû¸¦ ¸ÂÃá µíÀÌ °áÇյǾî ÀÖ´Ù. ¨é ¿¬°ñ °áÇÕ : Á¿ìÀÇ Ä¡°ñÀ̳ª ôÃß°ñ »çÀÌ¿¡´Â ¿¬°ñ Á¶Á÷ÀÌ ÀÖ¾î ±×°ÍÀÌ °ñ°Ý°ú °ñ°ÝÀ» °áÇÕ½ÃŲ´Ù.
  • capsule structure
    ³¶ ±¸Á¶, °üÀý³¶ ±¸Á¶
  • chain structure
    ¿¬¼â ±¸Á¶
  • chemical structure
    È­ÇÐ ±¸Á¶
  • cubic structure
    µî¹æ ±¸Á¶, ÀÔ¹æ ±¸Á¶
  • decidua structure
    Å»¶ô¸· ±¸Á¶
  • diencephalic structure
    °£³ú ±¸Á¶
  • domain structure
    ¿µ¿ª ±¸Á¶
  • electron structure of atom
    ¿øÀÚÀÇ ÀüÀÚ ±¸Á¶
  • encapsulated structure
    Çdz¶ ±¸Á¶
  • extracranial structure
    µÎ°³¿Ü ±¸Á¶¹°
  • locomotor structure
    ¿îµ¿ ±¸Á¶¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Holliday structure <molecular biology> A structure which occurs during homologous recombination between homologous chromosomes. While the two chromosomes are side by side, one strand of DNA on each chromosome is broken and then attached to the broken strand of DNA on the other chromosome. The crossover point, which is called the Holliday junction, is able to slide up and down between the two chromosomes, so that a little or a lot of DNA can ultimately be switched between them.
(09 Oct 1997)
soil structure The combination or arrangement of primary soil particles into secondary particles, units or peds.
(09 Oct 1997)
stem and loop structure <molecular biology> The structure of tRNAs is so termed because it has four base paired stems and three loops (not base paired), one of which contains the anticodon.
(18 Nov 1997)
structure <microscopy> The mode of construction of an animate or inanimate body or system from units such as atoms, ions, molecules, cells, crystals in a fluid, plastic, or solid state. Cf. Morphology.
(05 Aug 1998)
structure activity analysis Study in which systematic variation in the structure of a compound is correlated with its activity, in an attempt to determine the characteristics of the (receptor) site at which it acts.
(18 Nov 1997)
structure-activity relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects.
(12 Dec 1998)
structure-functionalism The scientific tradition that stresses the relationship between aphysical structure and its function, for example: the related disciplinesof anatomy and physiology.
(09 Oct 1997)
structure proteins Proteins whose role is for structure and support in tissue and within the cell; e.g., the collagens.
(05 Mar 2000)
quarternary structure The three-dimensional structure of a complex protein, this especially refers to the way the subunits fit together.
(09 Oct 1997)
quaternary structure The three-dimensional structure of a complex protein, this especially refers to the way the polypeptide subunits fit together.
(09 Oct 1997)
tertiary structure <biochemistry, chemistry> The third level of structural organisation in a macromolecule.
The primary structure of a protein (for example) is the amino acid sequence, the secondary structure is the folding of the peptide chain (alpha helical or beta pleated), the tertiary structure is the way in which the helices or sheets are folded or arranged to give the three dimensional structure of the protein. Quaternary structure refers to the arrangement of protomers in a multimeric protein.
(13 Jan 1998)
ecosystem structure The physical and spatial aspects of an ecosystem that are contributed by the biotic composition. Biotic composition is generally determined by the collective physiognomy of the dominant plants, including life forms, vertical stratification, and size.
(09 Oct 1997)
tuboreticular structure Tubules 20-30 nm in length that lie within cisterns of smooth endoplasmic reticulum; observed in connective tissue diseases such as SLE, and in various cancers and virus infections.
(05 Mar 2000)
fine structure <pathology> General term to describe the level of organisation that is below the level of resolution of the light microscope. In practice, a shorthand term for structure observed using the electron microscope, although other techniques could give information about structure in the sub micrometre range.
(18 Nov 1997)
fine structure mapping A technique of DNA mapping which makes use of extremely rare recombination events where the crossing over occurs between two genes or two alleles of a gene that are only a few nucleotides apart.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • crystal gazer
    ¼öÁ¤ Á¡ÀïÀÌ
  • crystal gazing
    ¼öÁ¤Á¡(¼öÁ¤¾Ë¿¡ ³ªÅ¸³ª´Â ȯ»çÀ¸·Î Á¡À» ħ)
  • crystal glass
    =CRYSTAL
  • crystal laser
    °áÁ¤·¹ÀÌÀú
  • crystal lattice
    °áÁ¤ °ÝÀÚ
  • crystal pickup
    (ÀüÃà¿ë)Å©¸®½ºÅÐ ÇȾ÷ 0
  • crystal set
    ±¤¼® ¼ö½Å±â
  • crystal vision
    ¼öÁ¤Á¡(¿¡¼­ º¸À̴ ȯ»ó)
  • crystal wedding
    ¼öÁ¤È¥½Ä(°áÈ¥ 15ÁÖ³âÀÇ ÃàÇϽÄ)
  • crystal-ball
    ¿¹¾ðÇÏ´Ù;Á¡Ä¡´Ù
  • crystal-seeing
    =CRYSTAL GAZING
  • crystal-seer
    =CRYSTAL GAZER
  • rock crystal
    (¹«»ö Åõ¸íÇÑ) ¼öÁ¤
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á